Research programme: anticancer monoclonal antibodies - Genmab/Scancell
Alternative Names: Human monoclonal antibodies programme - Genmab/ScancellLatest Information Update: 04 Apr 2008
At a glance
- Originator Genmab; Scancell
- Class Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 16 Oct 2001 Preclinical development for Cancer in Denmark (Parenteral)
- 16 Oct 2001 Preclinical development for Cancer in England (Parenteral)